Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:abacavir
|
| gptkbp:approvalYear |
1998
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J05AF06
|
| gptkbp:CASNumber |
136470-78-5
|
| gptkbp:contraindication |
HLA-B*5701 positive
|
| gptkbp:drugClass |
protease inhibitor
|
| gptkbp:eliminatedIn |
urine
|
| gptkbp:form |
gptkb:tablet
oral solution |
| gptkbp:halfLife |
1.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ziagen
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:ViiV_Healthcare
|
| gptkbp:MedlinePlusID |
a698037
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:PubChem_CID |
441300
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:RxNormID |
197798
|
| gptkbp:sideEffect |
fever
nausea vomiting hypersensitivity reaction |
| gptkbp:UNII |
X4D6WE122F
|
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:abacavir
|
| gptkbp:bfsLayer |
6
|